The Business Enterprise R&D Expenditure in Human Health and Social Work Activities in the US is forecasted to grow from $4.37 billion in 2024 to $7.03 billion by 2028. This represents a Compound Annual Growth Rate (CAGR) of approximately 12.4% over the five-year period, highlighting a robust upward trend. The year-on-year growth rates emphasize consistent acceleration, with a 15.3% increase from 2025 to 2026 and an 11.6% rise from 2026 to 2027, settling at about 10.4% from 2027 to 2028.
Looking ahead, key trends to monitor include technological advancements in healthcare, increased investment in health tech startups, and policy shifts favoring R&D tax incentives. These factors may drive further growth and innovation.
